Abstract
Keywords:
Acute pulmonary embolism; COVID-19; Deep vein thrombosis; SARS-CoV-2; Venous thromboembolism.
MeSH terms
-
Aged
-
Anticoagulants / therapeutic use
-
Betacoronavirus / drug effects
-
Betacoronavirus / isolation & purification
-
COVID-19
-
Coronavirus Infections / blood
-
Coronavirus Infections / complications*
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / virology
-
Enoxaparin / therapeutic use
-
Female
-
Fondaparinux / therapeutic use
-
Heparin / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / blood
-
Pneumonia, Viral / complications*
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / virology
-
Retrospective Studies
-
SARS-CoV-2
-
Treatment Outcome
-
Venous Thromboembolism / blood
-
Venous Thromboembolism / drug therapy
-
Venous Thromboembolism / etiology*
-
Venous Thromboembolism / virology
Substances
-
Anticoagulants
-
Enoxaparin
-
Heparin
-
Fondaparinux